JP2009515977A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009515977A5 JP2009515977A5 JP2008541285A JP2008541285A JP2009515977A5 JP 2009515977 A5 JP2009515977 A5 JP 2009515977A5 JP 2008541285 A JP2008541285 A JP 2008541285A JP 2008541285 A JP2008541285 A JP 2008541285A JP 2009515977 A5 JP2009515977 A5 JP 2009515977A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cancer
- pharmaceutical composition
- composition according
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73662005P | 2005-11-14 | 2005-11-14 | |
| US11/559,324 US7700136B2 (en) | 2005-11-14 | 2006-11-13 | Scutellaria barbata extract for the treatment of cancer |
| PCT/US2006/044224 WO2007059149A2 (en) | 2005-11-14 | 2006-11-14 | Scutellaria barbata extract for the treatment of cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009515977A JP2009515977A (ja) | 2009-04-16 |
| JP2009515977A5 true JP2009515977A5 (https=) | 2010-01-14 |
Family
ID=38041130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008541285A Pending JP2009515977A (ja) | 2005-11-14 | 2006-11-14 | 癌の治療のためのＳｃｕｔｅｌｌａｒｉａｂａｒｂａｔａ抽出物 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US7700136B2 (https=) |
| EP (1) | EP1965819A4 (https=) |
| JP (1) | JP2009515977A (https=) |
| AU (1) | AU2006315459A1 (https=) |
| CA (1) | CA2629638A1 (https=) |
| GB (2) | GB2448249A (https=) |
| WO (1) | WO2007059149A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134243A1 (en) * | 2004-12-17 | 2006-06-22 | Bionovo, Inc. | Method of using extracts of epimedium species |
| US7482029B2 (en) | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
| US7700136B2 (en) * | 2005-11-14 | 2010-04-20 | Bionovo, Inc. | Scutellaria barbata extract for the treatment of cancer |
| US20080319051A1 (en) * | 2007-06-22 | 2008-12-25 | Bionovo, Inc. | Liquiritigenin and derivatives as selective estrogen receptor beta agonists |
| US20090042818A1 (en) * | 2007-06-22 | 2009-02-12 | Bionovo, Inc. | Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists |
| WO2009021196A1 (en) * | 2007-08-08 | 2009-02-12 | Bionovo, Inc. | Extracts of ligustrum lucidum and uses thereof |
| AU2008296072A1 (en) * | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of Astragalus membranaceus Fisch.Bge.Var.mongolicus Bge. of the Leguminosae Family and uses thereof |
| AU2008296176A1 (en) * | 2007-09-07 | 2009-03-12 | Bionovo, Inc. | Estrogenic extracts of Asparagus conchinchinensis (Lour.) Merr of the Liliaceae Family and uses thereof |
| JP2010539086A (ja) * | 2007-09-07 | 2010-12-16 | バイオノボ・インコーポレーテッド | マメ科ファミリーのクズのエストロゲン性抽出物およびその使用 |
| EP2190292A4 (en) * | 2007-09-07 | 2012-12-26 | Bionovo Inc | ESTROGENWIRKSAME EXTRACTS OF SCUTTELARIA BARBATA D. DON OF THE FAMILY LABIATAE AND ITS USES |
| EP2222323A4 (en) * | 2007-11-19 | 2012-07-25 | Bionovo Inc | PROCESS FOR PREPARING A CLEANED EXTRACT OF SCUTELLARIA BARBATA D. DON |
| US20090130101A1 (en) * | 2007-11-19 | 2009-05-21 | Bionovo, Inc. | Anti-cancer therapy with an extract of scutellaria barbata |
| US20090130118A1 (en) * | 2007-11-19 | 2009-05-21 | Bionovo, Inc. | Scutellaria barbata extract and combinations for the treatment of cancer |
| EP2219659A4 (en) * | 2007-11-19 | 2010-11-17 | Bionovo Inc | METHODS OF DETECTION AND TREATMENT OF CANCERS USING BARBATA SCUTTELARIA EXTRACT |
| CA2721191A1 (en) * | 2008-04-14 | 2009-10-22 | Bionovo, Inc. | Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| WO2009137534A2 (en) * | 2008-05-06 | 2009-11-12 | Bionovo, Inc. | Estrogenic extracts for use in treating vaginal and vulvar atrophy |
| CA2726982A1 (en) * | 2008-06-05 | 2009-12-10 | Bionovo, Inc. | Method of quantification of multiple bioactives from botanical compositions |
| US20090312437A1 (en) * | 2008-06-06 | 2009-12-17 | Bionovo, Inc., A Delaware Corporation | Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions |
| AU2009311601A1 (en) * | 2008-06-13 | 2010-05-14 | Bionovo, Inc. | Nyasol and analogs thereof for the treatment of estrogen receptor beta-mediated diseases |
| EP2340027A4 (en) * | 2008-09-03 | 2012-04-04 | Bionovo Inc | METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER |
| WO2010110993A2 (en) * | 2009-03-24 | 2010-09-30 | Bionovo, Inc. | Methods and compositions for the treatment of cancer |
| CA2759671A1 (en) * | 2009-04-28 | 2010-11-11 | Bionovo, Inc. | Method of reducing fat accumulation and inducing weight loss |
| US8858953B2 (en) | 2011-05-09 | 2014-10-14 | Yu-Hwa Peter Sheng | Herbal composition for treating cancer |
| CN103599237B (zh) * | 2013-11-28 | 2015-06-03 | 姜永华 | 一种治疗瘀阻胃络型胃癌的中药及其制备方法 |
| US9789153B2 (en) | 2014-07-02 | 2017-10-17 | Hsiu-Hsien Tsai | Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1175485A1 (ru) * | 1983-12-21 | 1985-08-30 | Киевский Ордена Трудового Красного Знамени Медицинский Институт Им.Акад.А.А.Богомольца | Способ лечени гипертонической болезни (его варианты) |
| FR2616328B1 (fr) | 1987-06-12 | 1990-03-02 | Moet Hennessy Rech | Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant |
| JPH01175942A (ja) | 1987-12-28 | 1989-07-12 | Sanyo Kokusaku Pulp Co Ltd | 抗ウイルス性医薬用組成物 |
| US5437866A (en) * | 1989-11-03 | 1995-08-01 | Sun; Alexander S. | Herbal treatment of malignancy |
| JPH0725761A (ja) | 1993-07-09 | 1995-01-27 | Kureha Chem Ind Co Ltd | 軟骨保護剤 |
| US5874084A (en) | 1996-07-19 | 1999-02-23 | Yng-Wong; Quing Non | Using complex herbal formulations to treat hot flashes |
| WO1998042363A1 (en) | 1997-03-21 | 1998-10-01 | Shiseido Company, Ltd. | Immunopotentiators |
| MC2441A1 (fr) | 1997-07-31 | 1998-03-11 | Exsymol Sa | Composition cosmétique utile notamment pour le blanchiment de la peau et agent inhibiteur de la mélanogénèse comprenant une telle composition cosmétique |
| US6576660B1 (en) * | 1997-10-31 | 2003-06-10 | Arch Development Corporation | Methods and compositions for regulation of 5-α-reductase activity |
| US6294526B1 (en) * | 1998-02-06 | 2001-09-25 | Alps Pharmaceutical Ind. Co., Ltd. | Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA |
| FR2784294B1 (fr) | 1998-10-12 | 2000-11-17 | Oreal | Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique |
| US6304825B1 (en) | 1999-01-19 | 2001-10-16 | Xerox Corporation | Rotary encoder error compensation system and method for photoreceptor surface motion sensing and control |
| FR2791573B1 (fr) | 1999-03-30 | 2003-04-11 | Pf Medicament | Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate |
| JP2001122871A (ja) | 1999-10-26 | 2001-05-08 | Nippon Kayaku Co Ltd | エストロゲン様作用薬剤 |
| CN1294009A (zh) * | 1999-10-28 | 2001-05-09 | 马金发 | 抗癌中药制剂及其置备方法 |
| DE10031650A1 (de) | 2000-06-29 | 2002-01-17 | Schwabe Willmar Gmbh & Co | Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden |
| JP4693963B2 (ja) | 2000-07-12 | 2011-06-01 | 丸善製薬株式会社 | エストロゲン様作用剤、コラーゲン産生促進剤、及び線維芽細胞増殖剤 |
| US6238707B1 (en) | 2000-10-11 | 2001-05-29 | Zhang Chun | Herbal hormone balance composition |
| JP2005501816A (ja) * | 2000-12-12 | 2005-01-20 | ワックヴォム リミテッド | Ｓｃｕｔｅｌｌａｒｉａｅｂａｒｂａｔａｅから単離された活性な画分を含む組成物および使用方法 |
| US6551627B1 (en) | 2001-05-03 | 2003-04-22 | Holomed Pharmaceuticals, Ltd. | Medicinal herbal compounds for the prevention and treatment of diabetes |
| US6855344B2 (en) | 2001-07-17 | 2005-02-15 | Integrated Chinese Medicine Holdings, Ltd. | Compositions and methods for prostate and kidney health and disorders, an herbal preparation |
| US6750248B2 (en) | 2001-11-09 | 2004-06-15 | National University Of Singapore | Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
| US20030165588A1 (en) * | 2002-03-01 | 2003-09-04 | Unigen Pharmaceuticals, Inc. | Identification of free-B-ring flavonoids as potent COX-2 inhibitors |
| US20050032882A1 (en) | 2002-03-06 | 2005-02-10 | Sophie Chen | Botanical extract compositions and methods of use |
| JP2004155779A (ja) | 2002-10-16 | 2004-06-03 | Taisho Pharmaceut Co Ltd | 更年期症の予防・治療用経口組成物 |
| AU2002952453A0 (en) | 2002-11-01 | 2002-11-21 | Novogen Research Pty Ltd | Aminated isoflavonoid derivatives and uses thereof |
| CA2520532A1 (en) | 2003-03-28 | 2004-10-14 | Nihon University | Polynucleotide encoding 2-hydroxyisoflavanone dehydratase and use thereof |
| US20070122501A1 (en) | 2003-06-27 | 2007-05-31 | Hong Kong University Of Science And Technology | Formulations containing astragalus extracts and uses thereof |
| PL1663103T3 (pl) | 2003-09-08 | 2012-05-31 | Genyous Biomed Int Inc | Kompozycje roślinnych ekstraktów do leczenia nowotworu |
| US20050196409A1 (en) * | 2003-09-24 | 2005-09-08 | James Dao | Compositions of botanical extracts for treating malignancy-associated changes |
| US20070122492A1 (en) | 2004-11-18 | 2007-05-31 | Stephen Behr | Plant extracts and dermatological uses thereof |
| US20050208159A1 (en) | 2004-03-16 | 2005-09-22 | Kang Kyung S | Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin |
| WO2005107747A2 (en) | 2004-05-06 | 2005-11-17 | Bioresponse, Llc | Diindolymethane formulations for the treatment of leiomyomas |
| US20050260285A1 (en) * | 2004-05-21 | 2005-11-24 | Dimateeo-Leggio Giovina | Healthy prostate formula |
| EP1815014B1 (en) | 2004-11-05 | 2012-03-21 | Genomic Health, Inc. | Molecular indicators of breast cancer prognosis and prediction of treatment response |
| NZ555316A (en) | 2004-12-09 | 2009-08-28 | Merck & Co Inc | Estrogen receptor modulators |
| CA2588566A1 (en) | 2004-12-17 | 2006-06-22 | Bionovo, Inc. | Estrogenic extracts of morus alba and uses thereof |
| US20060134243A1 (en) | 2004-12-17 | 2006-06-22 | Bionovo, Inc. | Method of using extracts of epimedium species |
| US7482029B2 (en) | 2005-04-01 | 2009-01-27 | Bionovo, Inc. | Composition for treatment of menopause |
| CN100488524C (zh) | 2005-06-06 | 2009-05-20 | 广东医学院 | 一种由黄芪和司坦唑醇组成的治疗骨质疏松症的药物制剂 |
| EP1907858A4 (en) | 2005-06-13 | 2009-04-08 | Univ Michigan | COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER |
| CN1723989A (zh) | 2005-07-08 | 2006-01-25 | 山东省中医药研究院 | 葛藤提取物、制备方法及用途 |
| US7700136B2 (en) | 2005-11-14 | 2010-04-20 | Bionovo, Inc. | Scutellaria barbata extract for the treatment of cancer |
| HUE030390T2 (en) | 2005-12-21 | 2017-05-29 | Janssen Pharmaceutica Nv | Triazolopyridazines as tyrosine kinase modulators |
| CN1840134A (zh) | 2006-01-21 | 2006-10-04 | 端智 | 舒更颗粒 |
-
2006
- 2006-11-13 US US11/559,324 patent/US7700136B2/en not_active Expired - Fee Related
- 2006-11-14 CA CA002629638A patent/CA2629638A1/en not_active Abandoned
- 2006-11-14 GB GB0810224A patent/GB2448249A/en not_active Withdrawn
- 2006-11-14 EP EP06837591A patent/EP1965819A4/en not_active Withdrawn
- 2006-11-14 WO PCT/US2006/044224 patent/WO2007059149A2/en not_active Ceased
- 2006-11-14 JP JP2008541285A patent/JP2009515977A/ja active Pending
- 2006-11-14 AU AU2006315459A patent/AU2006315459A1/en not_active Abandoned
-
2008
- 2008-05-13 GB GBGB0808665.4A patent/GB0808665D0/en not_active Ceased
-
2010
- 2010-01-21 US US12/691,580 patent/US20100143511A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009515977A5 (https=) | ||
| He et al. | Current advances in coptidis rhizoma for gastrointestinal and other cancers | |
| JP2007505042A5 (https=) | ||
| NZ593641A (en) | Extended soluble ph20 polypeptides and uses thereof | |
| FI2547205T3 (fi) | Uusia menetelmiä syövän kantasolujen kohdentamiseksi | |
| RU2018137037A (ru) | Антинеопластические комбинации, содержащие hki-272 и винорелбин | |
| WO2010028187A3 (en) | Methods and compositions for the treatment of cancer | |
| NZ599031A (en) | A dosage form containing two or more active pharmaceutical ingredients in different physical forms | |
| HRP20192168T1 (hr) | Privremena zaštita normalnih stanica tijekom kemoterapije | |
| CN103417561A (zh) | 芍药苷类化合物在制备抗肿瘤药物中的用途 | |
| RU2012110580A (ru) | Способы скрининга in vivo | |
| JP2011522515A5 (https=) | ||
| Tai et al. | Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids | |
| JP2011157399A5 (https=) | ||
| Zhu et al. | Olean-28, 13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways | |
| WO2010144336A3 (en) | Methods for treating chronic kidney disease | |
| US11771731B2 (en) | Herbal composition PHY906 and its use in chemotherapy | |
| GB2448249A (en) | Scutellaria barbata extract for the treatment of cancer | |
| WO2009002808A3 (en) | Quinazolinone compounds and methods of use thereof | |
| Wang et al. | F-actin reorganization and inactivation of rho signaling pathway involved in the inhibitory effect of Coptidis Rhizoma on hepatoma cell migration | |
| JP2013537426A5 (https=) | ||
| WO2007065010A3 (en) | Anti-angiogenesis compounds | |
| JP2008519767A5 (https=) | ||
| JP2008524329A5 (https=) | ||
| WO2017091885A8 (en) | Monocarboxylate transporter 4 (mct4) antisense oligonucleotide (aso) inhibitors for use as therapeutics in the treatment of cancer |